<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>7</volume><submitter>Su YY</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>Single-cell RNA sequencing (scRNA-seq) is a powerful tool which can unveil regulatory connections between genes and cells. However, due to the high demand for tissue quality, most scRNA-seq for pancreatic cancer is carried out by surgical specimen. This study (NCT05767697) aims to gain practical experience in carrying out scRNA-seq using endoscopic ultrasound-guided fine-needle biopsy (EUS-FNB).&lt;h4>Materials and methods&lt;/h4>With a within-subjects design, two punctures from the same lesion, with a negative pressure of 5 ml (suction group) and without applying suction (non-suction group), were evaluated. Each biopsy sample was separated into three parts: white tissue, red material, and buffer for living cell counting. scRNA-seq was carried out according to the manufacturer</pubmed_abstract><journal>ESMO gastrointestinal oncology</journal><pagination>100113</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12836601</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Single-cell RNA sequencing via endoscopic ultrasound-guided fine-needle biopsy for pancreatic tumors uncovered an aggressive subclone with a poor prognosis.</pubmed_title><pmcid>PMC12836601</pmcid><pubmed_authors>Chen LT</pubmed_authors><pubmed_authors>Huang CJ</pubmed_authors><pubmed_authors>Cheng SM</pubmed_authors><pubmed_authors>Hsu CW</pubmed_authors><pubmed_authors>Liu YS</pubmed_authors><pubmed_authors>Yeh CM</pubmed_authors><pubmed_authors>Lin MY</pubmed_authors><pubmed_authors>Hou YC</pubmed_authors><pubmed_authors>Hwang DY</pubmed_authors><pubmed_authors>Su YY</pubmed_authors><pubmed_authors>Chang WL</pubmed_authors><pubmed_authors>Chao YJ</pubmed_authors><pubmed_authors>Shan YS</pubmed_authors><pubmed_authors>Yu CC</pubmed_authors></additional><is_claimable>false</is_claimable><name>Single-cell RNA sequencing via endoscopic ultrasound-guided fine-needle biopsy for pancreatic tumors uncovered an aggressive subclone with a poor prognosis.</name><description>&lt;h4>Background&lt;/h4>Single-cell RNA sequencing (scRNA-seq) is a powerful tool which can unveil regulatory connections between genes and cells. However, due to the high demand for tissue quality, most scRNA-seq for pancreatic cancer is carried out by surgical specimen. This study (NCT05767697) aims to gain practical experience in carrying out scRNA-seq using endoscopic ultrasound-guided fine-needle biopsy (EUS-FNB).&lt;h4>Materials and methods&lt;/h4>With a within-subjects design, two punctures from the same lesion, with a negative pressure of 5 ml (suction group) and without applying suction (non-suction group), were evaluated. Each biopsy sample was separated into three parts: white tissue, red material, and buffer for living cell counting. scRNA-seq was carried out according to the manufacturer</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Mar</publication><modification>2026-07-15T12:27:18.709Z</modification><creation>2026-07-04T03:13:05.395Z</creation></dates><accession>S-EPMC12836601</accession><cross_references><pubmed>41646484</pubmed><doi>10.1016/j.esmogo.2024.100113</doi></cross_references></HashMap>